Cargando…
Stated Preferences for Attributes of a CYP2C19 Pharmacogenetic Test Among the General Population Presented with a Hypothetical Acute Coronary Syndrome Scenario
BACKGROUND: Pharmacogenetic (PGx) testing identifies pharmacotherapeutic risks to permit personalized therapy. Identifying the genetic profile of patients with acute coronary syndrome (ACS) who are considered for therapy with clopidogrel (P2Y(12) receptor blockers) and acetylsalicylic acid (ASA) con...
Autores principales: | Bereza, Basil G, Coyle, Doug, So, Derek Y, Kadziola, Zbigniew, Wells, George, Grootendorst, Paul, Papadimitropoulos, Emmanuel A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090184/ https://www.ncbi.nlm.nih.gov/pubmed/32256091 http://dx.doi.org/10.2147/CEOR.S234298 |
Ejemplares similares
-
Preferred life expectancy and the association with hypothetical adverse life
scenarios among Norwegians aged 60+
por: Skirbekk, Vegard, et al.
Publicado: (2021) -
Financial burden of household out-of-pocket expenditures for prescription drugs: Cross-sectional analysis based on national survey data
por: McLeod, Logan, et al.
Publicado: (2011) -
Schadenfreude is higher in real-life situations compared to hypothetical scenarios
por: Gonzalez-Gadea, Maria Luz, et al.
Publicado: (2018) -
A Markov Model Approach Assessing the Cost of Illness of Generalized Anxiety Disorder in Canada
por: Bereza, Basil G., et al.
Publicado: (2012) -
6. Dose Adjustments Based on Pharmacogenetics of CYP450 Enzymes
por: van Schaik, Ron H.N.
Publicado: (2008)